Nova Leap Health (CVE:NLH) Reaches New 52-Week High – Still a Buy?

Nova Leap Health Corp. (CVE:NLH)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$0.44 and last traded at C$0.44, with a volume of 6510 shares. The stock had previously closed at C$0.43.

Nova Leap Health Trading Up 1.1%

The firm’s fifty day simple moving average is C$0.39 and its 200 day simple moving average is C$0.36. The stock has a market capitalization of C$38.42 million, a P/E ratio of 146.67 and a beta of 1.70. The company has a debt-to-equity ratio of 14.80, a quick ratio of 1.13 and a current ratio of 1.02.

Insiders Place Their Bets

In related news, Director R. Wayne Myles purchased 61,000 shares of Nova Leap Health stock in a transaction dated Friday, May 15th. The shares were bought at an average cost of C$0.44 per share, for a total transaction of C$26,840.00. Following the purchase, the director owned 2,446,761 shares in the company, valued at approximately C$1,076,574.84. This trade represents a 2.56% increase in their position. Insiders bought 168,471 shares of company stock valued at $69,930 over the last quarter. Company insiders own 40.77% of the company’s stock.

Nova Leap Health Company Profile

Nova Leap Health Corp., together with its subsidiaries, provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders. The company was incorporated in 2015 and is headquartered in Halifax, Canada.